Clinical trial · Interventional
Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia
Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia: A Randomized Controlled Trial
NCT05818748CI-TRIAL-00065781VR-EgeunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aim to evaluate the effect of virtual reality distraction on symptom management and anxiety in children aged 7-18 years with leukemia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Symptom Cluster | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| virtual reality | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- virtual reality distraction
- description
- watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment
- interventionNames
- Device: virtual reality
- type
- NO_INTERVENTION
- label
- control
- description
- no virtual reality distraction
Primary outcomes (2)
- measure
- Change in symptom cluster
- timeFrame
- during the 1st, 2nd and 3rd days of chemotherapy treatment
- description
- Symptom by Symptom Screening Tool(8-18) in SSPedi-Pediatric Patients with Cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 7 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pediatric patients aged 7-18 years receiving leukemia treatment in the Pediatric Hematology Service * 4 weeks after diagnosis (not in the induction phase) * No need for blood product transfusion (less than 8 mg/dl for hematological malignancies, less than 7 mg/dl for oncological malignancies) * Consent to voluntarily participate in the study and written consent from the child and parent Exclusion Criteria: * The child has a physical and psychological deficit that will prevent him from wearing glasses to watch virtual reality * Having a symptom of nausea and vomiting * Being in a terminal period * Undergoing a surgical operation * Unwillingness to participate in the study * Having a history of vertigo (having a history of train, motion sickness) * The child and family do not know Turkish
References
Publications (0)
Data not yet available
No reference posted for this study.